Listen to Post Strategies to ease the burden Multiple Sclerosis (MS) is a chronic neurological condition that ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

Cigna Group shares slumped after the health insurer reported cost pressures from surprisingly high catastrophic medical ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

The U.S. Food and Drug Administration has designated SetPoint Medical’s neurostimulator a breakthrough device for the treatment of relapsing-remitting multiple sclerosis (RRMS). This designation ...

PIPE-307 is under clinical development by Janssen Pharmaceutica and currently in Phase II for Relapsing Remitting Multiple Sclerosis (RRMS). According to GlobalData, Phase II drugs for Relapsing ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Therapy for multiple sclerosis progression is a third major research theme. Inhibitors of Bruton's tyrosine kinase (BTK), an intracellular signalling enzyme expressed in B cells and most innate immune ...

Research indicates CBD may play a promising complementary role in pain management ... Despite these benefits, it’s best to consult a medical professional before trying any CBD product for ...

Multiple sclerosis (MS) is an autoimmune neurological ... Both conditions require a variety of medical tests for a diagnosis. Before you begin any tests, you may be able to distinguish your ...

the programme is targeted toward treatment of neurological diseases with high unmet medical need, with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs when the immune ...

PTD802 is aimed at promoting remyelination in individuals with neurological conditions, particularly multiple sclerosis. Credit: New Africa/Shutterstock. Pheno Therapeutics has gained clinical trial ...